| Crystal structure and oligomeric state of the RetS signaling kinase sensory domain X Jing, J Jaw, HH Robinson, FD Schubot Proteins: Structure, Function, and Bioinformatics 78 (7), 1631-1640, 2010 | 39 | 2010 |
| Analysis of the Crystal Structure of the ExsC·ExsE Complex Reveals Distinctive Binding Interactions of the Pseudomonas aeruginosa Type III Secretion Chaperone … NJ Vogelaar, X Jing, HH Robinson, FD Schubot Biochemistry 49 (28), 5870-5879, 2010 | 33 | 2010 |
| The catalytic domain of the germination‐specific lytic transglycosylase SleB from Bacillus anthracis displays a unique active site topology X Jing, HR Robinson, JD Heffron, DL Popham, FD Schubot Proteins: Structure, Function, and Bioinformatics 80 (10), 2469-2475, 2012 | 32 | 2012 |
| Structural evidence suggests that antiactivator ExsD from Pseudomonas aeruginosa is a DNA binding protein RC Bernhards, X Jing, NJ Vogelaar, H Robinson, FD Schubot Protein Science 18 (3), 503-513, 2009 | 24 | 2009 |
| The type IV pilus assembly ATPase PilB functions as a signaling protein to regulate exopolysaccharide production in Myxococcus xanthus WP Black, L Wang, X Jing, RC Saldaña, F Li, BE Scharf, FD Schubot, ... Scientific reports 7 (1), 7263, 2017 | 22 | 2017 |
| Update on therapeutic protein–drug interaction: information in labeling X Jing, P Ji, SJ Schrieber, EP Fletcher, C Sahajwalla Clinical pharmacokinetics 59, 25-36, 2020 | 19 | 2020 |
| Clinical Pharmacology of RNA Interference–Based Therapeutics: A Summary Based on Food and Drug Administration–Approved Small Interfering RNAs X Jing, V Arya, KS Reynolds, H Rogers Drug Metabolism and Disposition 51 (2), 193-198, 2023 | 13 | 2023 |
| Key physicochemical characteristics influencing adme properties of therapeutic proteins X Jing, Y Hou, W Hallett, CG Sahajwalla, P Ji Therapeutic Enzymes: Function and Clinical Implications, 115-129, 2019 | 7 | 2019 |
| The type IV pilus assembly ATPase PilB functions as a signaling protein to regulate exopolysaccharide production in Myxococcus xanthus. Sci Rep 7: 7263 WP Black, L Wang, X Jing, RC Saldana, F Li, BE Scharf, FD Schubot, ... | 6 | 2017 |
| Clinical pharmacology of RNAi-based therapeutics: a summary based on FDA-approved small-interfering RNAs X Jing, V Arya, KS Reynolds, H Rogers Drug Metabolism and Disposition, 2022 | 4 | 2022 |
| Structural and Functional Studies of Sensor Kinase RetS from Pseudomonas aeruginosa and Peptidoglycan Hydrolase SleB from Bacillus anthracis X Jing Virginia Tech, 2013 | | 2013 |
